Cargando…

Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries

Background: The West Africa Health Organization launched the West Africa Medicines Regulatory Harmonization Project (WA-MRH) in 2017 with the overarching objective to improve the availability of high-quality, safe and effective medicines and vaccines by the 15 countries in the Economic Community of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owusu-Asante, Mercy, Darko, Delese Mimi, Walker, Stuart, Salek, Sam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732020/ https://www.ncbi.nlm.nih.gov/pubmed/36506579 http://dx.doi.org/10.3389/fphar.2022.1069345

Ejemplares similares

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry
por: Owusu-Asante, Mercy, et al.
Publicado: (2023)

Evaluation of the Food and Drugs Authority, Ghana Regulatory Review Process: Challenges and Opportunities
por: Owusu-Asante, Mercy, et al.
Publicado: (2022)

Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward
por: Ngum, Nancy, et al.
Publicado: (2022)

The South African Regulatory System: Past, Present, and Future
por: Keyter, Andrea, et al.
Publicado: (2018)

Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documents
por: Leong Wai Yeen, James, et al.
Publicado: (2014)

Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices
por: Rahalkar, Hasumati, et al.
Publicado: (2021)

Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature
por: Bujar, Magdalena, et al.
Publicado: (2017)

South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access
por: Keyter, Andrea, et al.
Publicado: (2021)

Needs‐driven talent and competency development for the next generation of regulatory scientists in Africa
por: Semete‐Makokotlela, Boitumelo, et al.
Publicado: (2021)

A practical approach to communicating benefit-risk decisions of medicines to stakeholders
por: Leong, James, et al.
Publicado: (2015)

The Development and Validation of a Generic Instrument, QoDoS, for Assessing the Quality of Decision Making
por: Donelan, Ronan, et al.
Publicado: (2016)

Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities
por: McAuslane, Neil, et al.
Publicado: (2023)

The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System
por: Keyter, Andrea, et al.
Publicado: (2018)

The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland
por: Keyter, Andrea, et al.
Publicado: (2019)

Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?
por: Keyter, Andrea, et al.
Publicado: (2020)

The Reliability and Relevance of a Quality of Decision Making Instrument, Quality of Decision-Making Orientation Scheme (QoDoS), for Use During the Lifecycle of Medicines
por: Bujar, Magdalena, et al.
Publicado: (2019)

A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?
por: Allen, Nicola, et al.
Publicado: (2017)

Evaluation of the Performance of the South Africa Regulatory Agency: Recommendations for Improved Patients’ Access to Medicines
por: Keyter, Andrea, et al.
Publicado: (2019)

The Relevance of Genomic Epidemiology for Control of Tuberculosis in West Africa
por: Asare, Prince, et al.
Publicado: (2021)

Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement
por: Ngum, Nancy, et al.
Publicado: (2022)

Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines
por: Rahalkar, Hasumati, et al.
Publicado: (2018)

Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
por: Sithole, Tariro, et al.
Publicado: (2022)

Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities
por: Rahalkar, Hasumati, et al.
Publicado: (2021)

Mapping the regulatory landscape of AI in healthcare in Africa
por: Townsend, Beverley Alice, et al.
Publicado: (2023)

Evaluation of surveillance system for post market activities on pre-packaged foods in Greater Accra Region, Ghana, 2021
por: Osei Tutu, Benjamin, et al.
Publicado: (2022)

Anti-HCV Tannins From Plants Traditionally Used in West Africa and Extracted With Green Solvents
por: Bamba, Moussa, et al.
Publicado: (2022)

Implementation of a Framework for an Abridged Review Using Good Reliance Practices: Optimising the Medicine Regulatory Review Process in South Africa
por: Keyter, Andrea, et al.
Publicado: (2020)

Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative
por: Giaquinto, Alexander R., et al.
Publicado: (2020)

Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities
por: Sithole, Tariro, et al.
Publicado: (2021)

A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency
por: Keyter, Andrea, et al.
Publicado: (2020)

Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients’ Access to Medicines
por: Koyuncu, Oguzhan, et al.
Publicado: (2020)

Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities
por: Danks, Lorraine, et al.
Publicado: (2023)

Reduced transmission of Mycobacterium africanum compared to Mycobacterium tuberculosis in urban West Africa
por: Asare, Prince, et al.
Publicado: (2018)

Genotypic and phenotypic diversity of Mycobacterium tuberculosis complex genotypes prevalent in West Africa
por: Osei-Wusu, Stephen, et al.
Publicado: (2021)

Harmonization Initiatives in Europe
por: Ceriotti, Ferruccio
Publicado: (2016)

Evaluating the Success of ZaZiBoNa, the Southern African Development Community Collaborative Medicines Registration Initiative
por: Sithole, Tariro, et al.
Publicado: (2020)

Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
por: Sithole, Tariro, et al.
Publicado: (2022)

Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2023)

Neglected Tropical Diseases in the Ebola-Affected Countries of West Africa
por: Hotez, Peter J.
Publicado: (2015)

Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study
por: Meyer, Johanna C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5icg2o6ofklilrecit04896r4p